HeideggerCPBergerMMNGrafS. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomized controlled trial. Lancet. 2013;381:385-393.
2.
HigginsJPTAltmanDGSterneJAC. Assessing risk of bias in included studies. In: HigginsJPTGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
3.
SchulzKFChalmersIHayesRJAltmanDG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995; 273:408-412.
4.
KoretzRL. JPEN Journal Club 8. Concealment of allocation. JPEN J Parenter Enteral Nutr. 2014;38:1007-1008.
5.
GuyattGHOxmanADMontonV. GRADE guidelines: 5. Rating the quality of evidence—publication bias. J Clin Epidemiol. 2011;64:1277-1282.
6.
TurnerEHMatthewsAMLinardatosETellRARosenthalR. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
7.
KoretzRLLipmanTOKleinS. AGA technical review—parenteral nutrition. Gastroenterology. 2001;121:970-1001.
MathieuSBoutronIMoherDAltmanDGRavaudP. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302:977-984.
11.
HartBLundhABeroL. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2011;344:d7202.
